Pharma Journalist -

Cardurion Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug Application (IND) for CRD-733, a Phosphodiesterase-9…
Read More...

Aphena Pharma Solutions Inc. has expanded its DEA operations and storage in both its Maryland and Tennessee manufacturing locations. Aphena's liquid and semisolids division in Easton,…
Read More...

BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer,…
Read More...

Zosano Pharma Corporation announced the release of three registration batches of M207, the Company’s lead development candidate. The registration batches will be used to support…
Read More...

Molecular Templates announced an agreement with Takeda Pharmaceutical Company Limited (Takeda) for the joint development of CD38-targeted engineered toxin bodies (ETBs) for the…
Read More...

Abzena has signed an antibody humanisation agreement with Tmunity Therapeutics (Tmunity), a clinical stage T cell therapy company and a leader in the development of new Chimeric Antigen…
Read More...

Propanc Biopharma announced the execution of a research collaboration agreement with the University of Jaén, Spain, for the provision of research services and scientific technical…
Read More...

Adverum Biotechnologies announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ADVM-022. ADVM-022 is a novel gene therapy candidate for the…
Read More...

AstraZeneca announced results from the BORA Phase III extension trial evaluating the long-term safety and efficacy of Fasenra (benralizumab) as an add-on maintenance treatment in…
Read More...

Just Biotherapeutics and Pandion Therapeutics announced that they have entered into an agreement for the development and cGMP clinical manufacturing by Just of Pandion’s lead program.…
Read More...